Business
Communiqué from the Annual General Meeting of AlzeCure Pharma on 14 May 2025
STOCKHOLM, SE / ACCESS Newswire / May 14, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - Today, 14 May 2025, the annual general meeting was held in AlzeCure Pharma AB (publ) (the "Company"). Below is a summary of the resolutions made. All resolutions ...
About this update from Alzecure Pharma Ab
[{"type":"text","content":"STOCKHOLM, SE / ACCESS Newswire / May 14, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - Today, 14 May 2025, the annual general meeting was held in AlzeCure Pharma AB (publ) (the "Company"). Below is a summary of the resolutions made. All resolutions were passed with the required majority.","length":300,"tagName":"p"},{"type":"text","content":"Resolution regarding the adoption of the accounts and allocation of the Company's resultThe annual general meeting resolved to adopt the profit and loss statement and the balance sheet. The annual general meeting also resolved to allocate the Company's result in accordance with the board of directors' and the CEO's proposal, meaning that no dividend is paid to the shareholders, and that available funds are carried forward.","length":443,"tagName":"p"},{"type":"text","content":"Discharge from liability for the members of the board of directors and the managing directorThe annual general meeting resolved to grant discharge from liability to the members of the board of directors and the managing director for the financial year 2024.","length":258,"tagName":"p"},{"type":"text","content":"Election of and remuneration to the board of directors and the auditorThe annual general meeting resolved, in accordance with the nomination committees' proposal, on re-election of Thomas Pollare, Ragnar Linder, Janet Hoogstraate, Eva Lilienberg and Jan Lundberg as ordinary members of the board of directors. Thomas Pollare was re-elected as chairman of the board of directors.","length":383,"tagName":"p"},{"type":"text","content":"The annual general meeting further resolved that the remuneration to the board of directors shall be SEK 270,000 to the chairman and SEK 135,000 to each of the other board members who are not employed by the Company.","length":216,"tagName":"p"},{"type":"text","content":"The annual general meeting also resolved to, in accordance with the nomination committees´ proposal, re-elect Grant Thornton AB as auditor and that the auditor shall be paid according to approved invoice. Grant Thornton AB has announced that the certified accountant Camilla Nilsson will be the auditor in charge.","length":313,"tagName":"p"},{"type":"text","content":"Resolution on the approval of the remuneration reportThe annual general meeting resolved to approve the board of director...